Insulin Mimetics Pty. Ltd. deal

Insulin Mimetics, a subsidiary of Melbourne Australia Investments Ltd., will provide $2.75 million for a two-year collaboration between Curtain University of Technology (Australia) and the University of California at San Francisco to develop oral insulin.

Curtain researchers have described the molecular site where insulin fits into its cell-surface receptor. UCSF will use computer-assisted modeling to design a molecule that resembles a part of the insulin hormone. ...